Major Depressive Disorder Steroid Treatment Gets FDA Fast Track Designation
Major depressive disorder could find a potential new treatment in SAGE-217, which received FDA fast track designation.
Lea Eslava-Kim, PharmD
Drug Information Specialist https://www.psychiatryadvisor.com
Lea Eslava-Kim, PharmD, is a Drug Information Specialist for MPR. She received her doctorate in pharmacy from the Ernest Mario School of Pharmacy, Rutgers University and completed her pharmacy residency at Clara Maass Medical Center. She is a licensed pharmacist.
